Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Mookerjee, R.P.; Pavesi, M.; Thomsen, K.L.; Mehta, G.; Macnaughtan, J.; Bendtsen, F.; ... ; CANONIC Study Investigatos (2016)

Article / Letter to editor

• Acute-on-chronic liver failure
• Cirrhosis
• Multi-organ failure
• Sepsis
• Prognosis
• Non-selective beta blockers

• All authors: Mookerjee, R.P.; Pavesi, M.; Thomsen, K.L.; Mehta, G.; Macnaughtan, J.; Bendtsen, F.; Coenraad, M.; Sperl, J.; Gines, P.; Moreau, R.; Arroyo, V.; Jalan, R.; CANONIC Study Investigatos
• Date: 2016-03-31
• Journal: Journal of Hepatology
• Volume: 64
• Issue: 3
• Pages: 574 - 582